SETD2 and acute myeloid leukemia: Pooled screening of JmjC domain-targeting sgRNAs in different AML cells indicated that, of those tested, only MOLM-13 and NOMO-1 are sensitive to JmjC domain disruption, while HEL, U-937, THP-1, and SET-2 are insensitive to JmjC domain targeting (Fig. S5B; Table S3).